Immunomedics Inc (IMMU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2005 | 06-2004 | 06-2003 | 06-2002 | 06-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,559 | -22,355 | -7,874 | -3,747 | -4,751 |
| Depreciation Amortization | 2,355 | 2,165 | 1,814 | 1,224 | 1,074 |
| Accounts receivable | 485 | 142 | 69 | -477 | -243 |
| Other Working Capital | 3,189 | 949 | -7,845 | -5,700 | 14,659 |
| Other Operating Activity | -1,652 | 402 | 485 | 1,141 | 792 |
| Operating Cash Flow | $-22,182 | $-18,698 | $-13,351 | $-7,559 | $11,531 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -483 | -1,181 | -7,296 | -4,105 | -375 |
| Purchase Of Investment | -7,357 | -850 | -10,230 | -13,878 | -53,295 |
| Sale Of Investment | 9,268 | 7,487 | 25,038 | 26,825 | 38,590 |
| Other Investing Activity | 0 | 0 | 0 | 2,542 | 0 |
| Investing Cash Flow | $1,428 | $5,456 | $7,512 | $11,384 | $-15,081 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 30,168 | 10,000 | N/A | N/A | N/A |
| Debt Repayment | -6,275 | -1,275 | N/A | -70 | -158 |
| Common Stock Issued | 13,961 | N/A | N/A | 377 | N/A |
| Other Financing Activity | -14,296 | 49 | 6,377 | 323 | 1,202 |
| Financing Cash Flow | $23,558 | $8,774 | $6,377 | $629 | $1,044 |
| Beginning Cash Position | 9,133 | 13,602 | 13,063 | 8,608 | 11,114 |
| End Cash Position | 11,938 | 9,133 | 13,602 | 13,063 | 8,608 |
| Net Cash Flow | $2,804 | $-4,468 | $539 | $4,455 | $-2,506 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,182 | -18,698 | -13,351 | -7,559 | 11,531 |
| Capital Expenditure | -483 | -1,181 | -7,296 | -4,105 | -375 |
| Free Cash Flow | -22,665 | -19,880 | -20,647 | -11,664 | 11,156 |